This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Use Patterns for Antipsychotic Medications in Medicaid Patients With Schizophrenia

Article Abstract

Objective: We investigated the use patterns for antipsychotic medications generated by Medicaid patients with schizophrenia. Method: Paid claims data from the California Medicaid program (Medi-Cal) were used to identify 2655 patients with schizophrenia. Data from 1987-1996 were used, duringwhich time Medi-Cal maintained prior authorization restrictions on second generation antipsychoticdrugs. Prescription records were used to identify 3 patterns of antipsychotic drug use: no drug therapyfor over 1 year; delayed onset of antipsychotic drug therapy; and switches in antipsychotic drugswithin 1 year. Multiple logistic regression models were used to identify factors affecting these antipsychoticdrug use patterns. Results: Conventional antipsychotic medications account for over 98%of all patient treatment episodes. Over 24% of patients with schizophrenia do not use any antipsychoticmedication for periods lasting up to 1 year. Over 24% of treated patients delayed the use of antipsychoticmedications at least 30 days. For those patients who did not delay their use of antipsychoticmedications, over 47% switched or augmented their initial antipsychotic medication during the firsttreatment year. Only 11.6% of treated patients achieved 1 year of uninterrupted antipsychotic drugtherapy. The mean duration of uninterrupted therapy was 142 days. Discussion: Antipsychotic drug use patterns suggest that conventional antipsychotic medications do not meet the therapeutic needs ofpatients with schizophrenia.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Neurologic and Neurocognitive , Neurology